Excellent Story On Breakthrough Cases From Wall St Journal

  • Context: COVID 
  • Thread starter Thread starter bhobba
  • Start date Start date
  • Tags Tags
    Journal Wall
Click For Summary
SUMMARY

The Wall Street Journal reported that COVID-19 breakthrough cases remain uncommon in the U.S., even with the Delta variant's spread. Despite concerns about Delta, hospitalization and severe disease prevention remains highly effective, with estimates ranging from 88% to 96% effectiveness based on data from Israel and the UK. The discussion highlights the need for booster shots approximately six months after the second dose, as indicated by healthcare professionals. Additionally, the situation in New South Wales is worsening despite lockdown measures, emphasizing the pandemic's impact on unvaccinated populations.

PREREQUISITES
  • Understanding of COVID-19 vaccination protocols
  • Familiarity with Delta variant characteristics
  • Knowledge of vaccine efficacy statistics
  • Awareness of public health measures and their implications
NEXT STEPS
  • Research COVID-19 vaccine booster recommendations and guidelines
  • Explore the latest data on Delta variant transmission rates
  • Investigate vaccine efficacy studies from Israel and the UK
  • Examine public health responses to rising COVID-19 cases in Australia
USEFUL FOR

Public health officials, healthcare professionals, epidemiologists, and individuals interested in understanding COVID-19 vaccination effectiveness and public health strategies.

Messages
10,974
Reaction score
3,840
I get the Audio of the Wall St Journal every day. They had a surprising and excellent story on breakthrough cases. The bottom line is the US is seeing very few - even with Delta. The full story is behind a paywall, but non-subscribers can view some of it here:
https://www.wsj.com/articles/as-delta-surges-covid-19-breakthrough-cases-remain-uncommon-11629199800

I am apprehensive about Delta. But maybe my worry is somewhat misplaced.

Thanks
Bill
 
Biology news on Phys.org
I'm not sure the headline should be about whether breakthroughs are common or uncommon, especially since the undercount on mildly symptomatic cases or asymptomatic cases may be large. The important point is that hospitalization or severe disease is still prevented with about 90% effectiveness, possibly higher (Israel preliminary estimates ~88-93%., UK estimates with 96% with 91-98% for the 95% confidence limits).
 
  • Love
Likes   Reactions: bhobba
atyy said:
I'm not sure the headline should be about whether breakthroughs are common or uncommon, especially since the undercount on mildly symptomatic cases or asymptomatic cases may be large.
Yes. When I was at my GP clinic Monday getting my AZ second dose, she (my usual doctor was busy) was matter of fact - we all will need third booster shots 6 months or so after the second jab:
https://www.aljazeera.com/news/2021...tions-rise-in-us-as-cdc-to-recommend-boosters

This is fast turning into a pandemic of the unvaccinated. At the moment, things are getting terrible in NSW despite a strong lockdown:
https://www.aljazeera.com/news/2021...tions-rise-in-us-as-cdc-to-recommend-boosters

Vaccination, in AUS, is accelerating quickly - which of course, it should. Surprisingly the largest uptake of the AZ vaccine is amongst the young. It s reassuring they are not being scared by the .5 in a million chance of dying.

Thanks
Bill
 

Similar threads

  • · Replies 47 ·
2
Replies
47
Views
10K
  • · Replies 1 ·
Replies
1
Views
2K
  • · Replies 65 ·
3
Replies
65
Views
11K